Grace Therapeutics (GRCE) Tax Rate (2022 - 2026)
Grace Therapeutics (GRCE) posted Tax Rate of 59.07% for Q1 2026, down 54.87% sequentially from 130.89% in Q1 2025, and down 7182.0% YoY from 0.83% in Q1 2025.
Grace Therapeutics (GRCE) Tax Rate (2022 - 2026) Analysis & Trends
Grace Therapeutics has reported Tax Rate for 5 years, with the latest figure at 59.07% in Q1 2026.
- Quarterly Tax Rate fell 7182.0% year-over-year to 59.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.91% (down 309.0% YoY) and the FY2026 annual result came in at 17.91%, down 309.0% from the prior year.
- Tax Rate eased to 59.07% in Q1 2026 per GRCE's latest filing, from 130.89% in the prior quarter.
- Over five years, Tax Rate peaked at 130.89% in Q1 2025 and troughed at 14.85% in Q1 2024.
- A 5-year average of 23.57% and a median of 10.0% in 2023 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2025 and 2026: Tax Rate surged 14574 bps in 2025, then sank 7182 bps in 2026.
- Over 5 years, Tax Rate stood at 6.58% in 2022, then grew by 22 bps to 8.0% in 2023, then surged by 59 bps to 12.71% in 2024, then soared by 930 bps to 130.89% in 2025, then sank by 55 bps to 59.07% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 59.07%, 130.89%, and 12.71% for Q1 2026, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 7.49% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.71% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 34.12% |
| 10 | Grace Therapeutics | 37.04 Mn | 37.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.07% |
| Mar 31, 2026 | 59.07% |
| Mar 31, 2026 | 59.07% |
| Mar 31, 2025 | 130.89% |
| Mar 31, 2025 | 130.89% |
| Mar 31, 2025 | 130.89% |
| Dec 31, 2024 | 12.71% |
| Dec 31, 2024 | 12.71% |
| Dec 31, 2024 | 12.71% |
| Sep 30, 2024 | 19.89% |
| Sep 30, 2024 | 19.89% |
| Sep 30, 2024 | 19.89% |
| Jun 30, 2024 | 21.67% |
| Jun 30, 2024 | 21.67% |
| Jun 30, 2024 | 21.67% |
| Mar 31, 2024 | -14.85% |
| Mar 31, 2024 | -14.85% |
| Mar 31, 2024 | -14.85% |
| Dec 31, 2023 | 8.00% |
| Dec 31, 2023 | 8.00% |